Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
Titel:
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
Auteur:
De Grève, Jacques Moran, Teresa Graas, Marie-Pascale Galdermans, Daniella Vuylsteke, Peter Canon, Jean-Luc Schallier, Denis Decoster, Lore Teugels, Erik Massey, Dan Chand, Vikram K. Vansteenkiste, Johan